Health Education Systems Incorporated (HESI) joins Elsevier

HESI products add high quality nursing and diagnostic tests to Elsevier portfolio

Amsterdam, January 9, 2006 - Elsevier, a world-leading healthcare and scientific publisher, announced today that it has finalized the acquisition of Health Education Systems Incorporated (HESI), a Houston-based firm that specializes in developing high-quality diagnostic tests for nursing and allied health markets. A primary objective of HESI products is to provide faculty with the tools to predict how their students will perform on the NCLEX exam, a licensure exam for nursing students. 

HESI, which will continue to be headquartered in Houston with a team of more than 30 employees, focuses on developing products that are recognized as best in market in terms of predictability of student success on the NCLEX exam. The current product offering includes the HESI Admission Assessment Exam, Specialty Exams, Custom Exams, Review Courses, and the HESI Exit Exam.  

HESI Founder and CEO, Dr. Susan Morrison, said, “HESI products are recognized by nurses in both academic and clinical practice settings as having exceptional outcome predictability, a feature that is highly valued by our clients. We believe strongly that this partnership with Elsevier provides a good strategic fit that will allow us to leverage Elsevier’s content assets with HESI’s capabilities to create testing products, thereby providing significant value to the health care industry.” 

 “HESI provides high quality products to our customers in the Nursing and Health Professions education market. Meeting the information and learning needs of nurses and healthcare professionals is core to Elsevier's business and we are very excited by the high caliber product offering that HESI brings,'' said Brian Nairn, CEO of Elsevier Health Sciences. 

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.

Media Contact: 
Marike Westra, Corporate Relations
Phone +1 31 (0)20 485 2736